Pharmacologic management by clinical pharmacists of behavioral and psychological symptoms of dementia in nursing home residents: Results from a pilot study

Pharmacotherapy

Volumn 23, Issue 2, 2003, Pages 217-221

  Rojas Fernandez, Carlos H ^a   Eng, Marty ^c   Allie, Nicole D ^b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^c School of Pharmacy ^*

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; AMLODIPINE; ATENOLOL; BISACODYL; CALCIUM CARBONATE; CELECOXIB; CYANOCOBALAMIN; DIGOXIN; DILTIAZEM; DONEPEZIL; FAMOTIDINE; FERROUS SULFATE; FINASTERIDE; GLYCERYL TRINITRATE; HYDROCHLOROTHIAZIDE; LISINOPRIL; LORAZEPAM; MULTIVITAMIN; NEUROLEPTIC AGENT; NIFEDIPINE; POTASSIUM CHLORIDE; QUETIAPINE; SERTRALINE; SPIRONOLACTONE; TORASEMIDE; TRAZODONE; TRIAMTERENE; UNINDEXED DRUG; VENLAFAXINE;

ADULT; AGED; ALGORITHM; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR; CLINICAL ARTICLE; CLINICAL PRACTICE; CONSULTATION; DRUG EFFECT; ELDERLY CARE; FEMALE; HUMAN; MALE; NURSING HOME; PHARMACIST; PRACTICE GUIDELINE; PSYCHOPHARMACOTHERAPY; RATING SCALE; SIDE EFFECT; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; DEMENTIA; FEMALE; GERIATRIC ASSESSMENT; HEALTH SERVICES FOR THE AGED; HOMES FOR THE AGED; HUMANS; MALE; MIDDLE AGED; NEW YORK; NURSING HOMES; OUTCOME ASSESSMENT (HEALTH CARE); PHARMACOLOGY, CLINICAL; PILOT PROJECTS; PSYCHOTROPIC DRUGS; TRAZODONE;

EID: 0037322085     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.23.2.217.32084     Document Type: Article

References (11)

1. O'Connor DW. Epidemiology of behavioral and psychological symptoms of dementia. Int Psychogeriatr 2000;12(suppl 1):41-6.
2. Finkel SI, Costa E, Silva J, et al. Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. Int Psychogeriatr 1996;8(suppl 3):497-500.
3. Anonymous. Practice guideline for the treatment of patients with Alzheimer's disease and other dementias of late life. Am J Psychiatry 1997;154(5 suppl):1-39.
4. Alexopoulos GS, Silver JM, Kahn DA, Frances A, Carpenter D. Treatment of agitation in older persons with dementia. Postgrad Med 1998:1-88.
5. Jenkins MH, Bond CA. The impact of clinical pharmacists on psychiatric patients. Pharmacotherapy 1996;16(4):708-14.
6. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association, 1994.
7. Rojas-Fernandez C, Lanctöt KL, Allen D, MacKnight C. Pharmacotherapy of behavioral and psychological symptoms of dementia: time for a different paradigm? Pharmacotherapy 2001;21(1):74-102.
8. Reisberg B, Borenstein J, Salob SP, Ferris SH, Franssen E, Georgotas A. Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. J Clin Psychiatry 1987;48(suppl 5):9-15.
9. DeDeyn PP, Rabheru K, Rasmussen A, et al. A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia. Neurology 1999;53:946-55.
10. Katz IR, Jeste DV, Mintzer JE, Clyde C, Napolitano J, Brecher M. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial: risperidone study group. J Clin Psychiatry 1999;60(2):107-15.
11. Cohen-Mansfield J, Marx MS, Rosenthal AS. A description of agitation in a nursing home. J Gerontol 1989;44:M77-84.